CanadaBis Capital Inc. (CANB.V)

CAD 0.04

(0.0%)

Total Debt Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual total debt in 2023 was 7.3 Million CAD , down -6.48% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly total debt in 2024 Q2 was 6.38 Million CAD , down -16.5% from previous quarter.
  • CanadaBis Capital Inc. reported annual total debt of 7.81 Million CAD in 2022, down -7.39% from previous year.
  • CanadaBis Capital Inc. reported annual total debt of 8.43 Million CAD in 2021, up 39.26% from previous year.
  • CanadaBis Capital Inc. reported quarterly total debt of 6.44 Million CAD for 2024 Q3, up 4.22% from previous quarter.
  • CanadaBis Capital Inc. reported quarterly total debt of 6.38 Million CAD for 2024 Q2, down -16.5% from previous quarter.

Annual Total Debt Chart of CanadaBis Capital Inc. (2023 - 2016)

Historical Annual Total Debt of CanadaBis Capital Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 7.3 Million CAD -6.48%
2022 7.81 Million CAD -7.39%
2021 8.43 Million CAD 39.26%
2020 6.06 Million CAD 220.25%
2019 1.89 Million CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%

Peer Total Debt Comparison of CanadaBis Capital Inc.

Name Total Debt Total Debt Difference
Aequus Pharmaceuticals Inc. 5.06 Million CAD -44.345%
Decibel Cannabis Company Inc. 40.96 Million CAD 82.157%
Delivra Health Brands Inc. 2.02 Million CAD -260.597%
Entourage Health Corp. 161.58 Million CAD 95.476%
Lifeist Wellness Inc. 1.26 Million CAD -477.347%
Cannara Biotech Inc. 45.78 Million CAD 84.035%
Medicure Inc. 544 Thousand CAD -1243.622%
PharmaCielo Ltd. 18.3 Million CAD 60.077%
Rubicon Organics Inc. 10.25 Million CAD 28.756%
BioSyent Inc. 1.22 Million CAD -498.611%
Voyageur Pharmaceuticals Ltd. 40 Thousand CAD -18173.26%